{"name":"Berkovich, Regina MD, PhD Inc.","slug":"berkovich-regina-md-phd-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Dosing Interruption of Natalizumab","genericName":"Dosing Interruption of Natalizumab","slug":"dosing-interruption-of-natalizumab","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Dosing Interruption of Natalizumab","genericName":"Dosing Interruption of Natalizumab","slug":"dosing-interruption-of-natalizumab","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxONGtxOW1SMWVGZWdrYjFiZ3VwTEItTEVxX1dnUGdfVHI0MWdUV3dxWEE4NEVqVVlPY1gzM0pZY21UWVFpOWFCcWlyVjVBNGVtbzl0N0dhVURaNnRGcUhBeFZod2htZkt1d0pOdVJ4NEpxZm85NC1tSWx0aDRjcU9NbnBFXzQ2UQ?oc=5","date":"2022-05-13","type":"pipeline","source":"NeurologyLive","summary":"Innate vs Adaptive Immunity in MS Management - NeurologyLive","headline":"Innate vs Adaptive Immunity in MS Management","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}